Begin main content

Calls for Patient Input: Dolutegravir and rilpivirine

Published on: November 23, 2017
Result type: News

CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website.

Dolutegravir and rilpivirine

Brand name Generic name Manufacturer Indication(s)
TBC Dolutegravir and rilpivirine ViiV Healthcare ULC HIV infection
Project Number Call for patient input Patient input deadline Submit patient input
SR0551-000 2017-11-23 2018-01-19 Submit